"Nurses are essential
collaborators in translational cancer research, bringing new and
effective treatments from the research laboratory to the patient,"
stated SU2C President and CEO, Sung Poblete, RN, PhD who holds a PhD in Nursing from Rutgers University.
"SU2C is at the forefront of immunoncology research and we recognize
that an essential part of bringing these cutting-edge therapies to
patients is the effective dissemination of information about the
treatments. Nurses play an integral role in patient management and these
modules will provide a new toolkit for patient care."
This site is for information on the various Chemo treatments and Stem Cell Therapies since 1992. This journey became bitter sweet in 2014, with the passing of my beautiful and dear wife. Sherry, had fought Non - Hodgkins Lymphoma(NHL) since 1990, in and out of remissions time and time again. From T-Cell therapies(1990's) to Dual Cord Blood Transplant(2014), she was in Clinical Trials over the years. This site is for informational purpose only and is not to promote the use of certain therapies.
Monday, May 9, 2016
Stand Up To Cancer offers nurse training for administering New Cancer Therapies
In recognition of Nurses Appreciation Week,
Stand Up To Cancer (SU2C) announces the development of a series of
Certification for Nursing Education (CNE) training modules by experts
from Boston College William F. Connell
School of Nursing. The CNE modules will equip nurses with the skills and
knowledge needed to manage the unique challenges and patient symptoms
that accompany administration of emerging immunotherapies to treat
cancer. The first of a series of the three web-based SU2C-Boston College Immunotherapy CNE modules will be available to nurses in July 2016.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment